Is extracorporeal shockwave lithotripsy (ESWL) appropriate for a patient with mild left hydronephrosis and proximal hydroureter caused by a 6 mm × 5 mm obstructive stone in the proximal ureter with high attenuation (~977 HU) and mild perinephric and peri‑ureteric fat stranding?

ESWL is a reasonable treatment option for this 6 mm proximal ureteral stone, though ureteroscopy may offer higher single-procedure success rates.

For this patient with a 6.1 × 4.7 mm proximal ureteral stone, both ESWL and ureteroscopy (URS) are appropriate first-line treatment options, with the choice depending on patient preference regarding anesthesia requirements, likelihood of needing repeat procedures, and stone characteristics. 1, 2, 3

Stone Size and Location Considerations

Your stone falls within the favorable size range for ESWL:

• Stone-free rates for ESWL in proximal ureteral stones are approximately 82% (based on meta-analysis of 6,428 patients) 1
• For stones <10 mm in the proximal ureter, both ESWL and URS are considered equivalent options 2, 3
• The stone requires an average of 0.62 additional procedures per patient when ESWL is chosen 1

Critical Factor: High Stone Attenuation (977 HU)

The 977 HU attenuation is a significant concern that reduces ESWL success probability. Research demonstrates that:

• High mean Hounsfield unit (HU) density predicts lower ESWL success rates 4
• Stones with lower HU values have relatively higher ESWL success rates 4
• The optimal cutoff for predicting success is approximately 857 HU, and your stone exceeds this threshold 4

This high attenuation suggests a harder stone composition that may be more resistant to shockwave fragmentation.

Hydronephrosis Impact

The mild hydronephrosis present in this case has conflicting evidence regarding ESWL outcomes:

• One 2006 study found that presence or degree of hydronephrosis does not affect ESWL success rates or stone clearance time 5
• However, a 2025 study showed that increasing degrees of hydronephrosis correlate with decreased ESWL success rates (85% overall success, but declining with higher grades) 6
• The mild perinephric and periureteric fat stranding indicates active inflammation but does not contraindicate ESWL 7

Treatment Algorithm

Given the specific characteristics of this stone, I recommend the following approach:

First-Line Options (in order of preference):

1. Ureteroscopy (URS) - Preferred given:

   • Higher single-procedure stone-free rate (81-93% for proximal stones) 1
   • High stone density (977 HU) predicts lower ESWL success 4
   • Achieves stone-free status in one procedure for most patients 1
   • Flexible URS achieves 87% stone-free rates for proximal stones 1

2. ESWL - Acceptable alternative if:

   • Patient prefers minimal anesthesia (ESWL uses IV sedation vs general anesthesia for URS) 1
   • Patient accepts 18% chance of treatment failure requiring additional procedures 1
   • Use stepwise energy ramping (start low, gradually increase) to minimize renal injury 7
   • Reduce shockwave frequency to 60-90/min (not 120/min) for better outcomes 7

Important Technical Points for ESWL if Chosen:

• No routine pre-stenting required - does not improve stone-free rates 1, 7
• Consider stent only if stone has low radiographic density for localization purposes 1
• Add medical expulsive therapy (alpha-blocker like tamsulosin) after ESWL to facilitate fragment passage 1, 7
• Maximum 2 ESWL sessions - if unsuccessful after 2 attempts, switch to URS 3

Contraindications to ESWL (none present in this case):

• Pregnancy 7
• Bleeding disorders 7
• Uncontrolled UTI 7
• Arterial aneurysm near stone 7
• Anatomic obstruction distal to stone 7

Common Pitfalls to Avoid

1. Do not ignore the high HU value - this is the strongest predictor against ESWL success in your case 4
2. Do not perform routine stenting before ESWL - increases morbidity without improving outcomes 1, 7
3. Do not exceed 2 ESWL sessions - switch to URS if first 2 attempts fail 3
4. Do not start ESWL at high energy - begin low and ramp up to reduce bleeding complications 3

Expected Outcomes

If ESWL chosen:

• 82% stone-free rate for proximal stones overall 1
• Lower success expected due to 977 HU density 4
• Mean clearance time: 13.7 days 5
• 18.43% minor complications (Clavien I-II), 2.48% major complications (Clavien III-IV) 7

If URS chosen:

• 81-93% stone-free rate in single procedure 1
• <5% perforation rate, <2% stricture rate 1
• Majority stone-free in one session 1